News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Fumiko Ladd Chino: Toxicity in phase III oncology clinical trials is often incompletely reported
Fumiko Ladd Chino/bumpintheroad.us
Apr 6, 2025, 12:55

Fumiko Ladd Chino: Toxicity in phase III oncology clinical trials is often incompletely reported

Fumiko Ladd Chino, Radiation Oncologist at MD Anderson Cancer Center, shared an article by Avital M. Miller et al on X:

“Toxicity in phase III oncology clinical trials is often incompletely reported and is frequently minimized in its interpretation.

Only 1/3 reported Grade 1 to 2 toxicities and toxicity-minimizing language was used in 46% (subjectively downplay the harm of drugs).”

Incomplete Toxicity Reporting and Use of Toxicity-Minimizing Language in Phase III Oncology Trials

Authors: Avital M. Miller et al

Fumiko Ladd Chino: Toxicity in phase III oncology clinical trials is often incompletely reported

Adina H Passy Alexander D. Sherry Avital M Miller cancer Esther J Beck Ethan B Ludmir Fumiko Ladd Chino Gabrielle S Kupferman Joseph Abi Jaoude OncoDaily Oncology Pavlos Msaouel Ramez Kouzy Timothy A Lin
Special Coverage
Blog
Jun 19, 2025, 16:01
IARC Marks World Kidney Cancer Day with New Video and Project Highlights
Science
Jun 19, 2025, 15:50
Alexey Kulikov Shared An Article on Cancer Vaccines and The Future of Immunotherapy
Opinion
Jun 19, 2025, 15:47
Mostafa Faisal: Primary Refractory AML and Allo-HCT - A 10-Year Retrospective Study from Japan
Blog
Jun 19, 2025, 15:36
Amol Akhade: KEYNOTE-689 - A Turning Point in Resectable HNSCC - Or a Cautious Step Forward?
Drugs
Jun 19, 2025, 15:30
Graham Collins: Nivo-AVD vs BV-AVD in Older Patients (60+) with Hodgkin Lymphoma
Blog
Jun 19, 2025, 15:15
Antonio Jimenez Jimenez Shared Findings from the Multicenter ACCESS trial, Supported by CIBMTR and NMDP
Blog
Jun 19, 2025, 14:35
Peter Pisters: Pleased to Join the 1st Institute for Cell Therapy Discovery and Innovation's External Advisory Board meeting
Insight
Jun 19, 2025, 14:22
Ron Alfa: Noetik and Agenus Announced an Exciting Collaboration to Deploy Foundation Models to Predict Immunotherapy Response
Blog
Jun 19, 2025, 13:42
Raffaele Colombo: Preclinical development of DB-1419 published on Clinical Cancer Research AACR
Blog
Jun 19, 2025, 13:21
Mohamed Kharfan-Dabaja: Happy to Share Our Clinical Practice Recommendations in CLL on behalf of ASTCT
Oncolibrary
Jun 19, 2025, 13:13
New Paper Alert: KEYNOTE-689. Neoadjuvant and Adjuvant Pembrolizumab Improves Survival in Locally Advanced HNC
Blog
Jun 19, 2025, 13:04
Raul Cordoba Shared FOLL12 Trial on the Role of PET in Follicular Lymphoma